MONDAY, Jan. 10, 2022 (HealthDay News) — Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer’s drug Aduhelm. U.S. Health and Human Services Secretary Xavier Becerra’s directive, which was announced on Monday, comes shortly after Aduhelm maker BiogenContinue Reading
MONDAY, Jan. 10, 2022 (HealthDay News) — Exercise helps you stay fit, hale and hearty, and researchers say it may also help you stave off dementia and Alzheimer’s disease. Now they have a better understanding of the hidden benefits that aid the brain. Older folks who are more physically activeContinue Reading
FRIDAY, Jan. 7, 2022 (HealthDay News) — Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer’s drug Aduhelm. The drug’s benefits are in question and its annual price tag tops $28,000. The U.S. CentersContinue Reading
THURSDAY, Jan. 6, 2022 (HealthDay News) — What’s good for the heart is good for the brain, and a new study suggests that connection might be especially critical for women. The study, of more than 1,800 adults in their 50s and 60s, found that those with heart disease, or riskContinue Reading
SUNDAY, Jan. 2, 2022 (HealthDay News) – When it comes to routine health screenings, resolve to include a memory assessment in 2022. The Alzheimer’s Foundation of America offers routine screenings that are both virtual and free every Monday, Wednesday and Friday. The process is quick, taking about 10 to 15Continue Reading
FRIDAY, Dec. 31, 2021 (HealthDay News) — A certain gene mutation known as APOE4 has long been known to raise the risk for Alzheimer’s disease. Now, researchers report it may also predispose people to increased susceptibility to COVID-19 infection and severe symptoms, including small brain bleeds. Researchers in Finland, whereContinue Reading
MONDAY, Dec. 20, 2021 (HealthDay News) — The maker of the pricey new Alzheimer’s drug Aduhelm (aducanumab) said Monday it will slash the cost of its medication in half, effective Jan. 1, 2022. The move follows widespread criticism of the drug’s original $56,000-a-year price tag. The reduction in the wholesaleContinue Reading
TUESDAY, Dec. 7, 2021 (HealthDay News) — People who undergo surgery to treat cataracts may have a lower likelihood of developing Alzheimer’s disease, a new study suggests. Of more than 3,000 older adults with the eye disease, those who had surgery were about 30% less likely to be diagnosed withContinue Reading
MONDAY, Dec. 6, 2021 (HealthDay News) — Viagra, a drug long used to treat erectile dysfunction, may double as a potential weapon against Alzheimer’s disease, a new study suggests. Looking at data on more than 7 million Americans, researchers found that those taking the drug were 69% less likely toContinue Reading
MONDAY, Dec. 6, 2021 (HealthDay News) — Checking older adults’ resting heart rate could help identify those who are more likely to experience a decline in mental function, a Swedish study suggests. The researchers found that a high resting heart rate was associated with a greater risk of dementia. “WeContinue Reading